100 Participants Needed

Cash Incentives for Type 2 Diabetes

(DMCT Trial)

Recruiting at 1 trial location
JA
JA
Overseen ByJennifer A Campbell, PhD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: State University of New York at Buffalo
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in 100 inner city AAs with poorly controlled T2DM using an RCT design. The aims of the proposed study include:AIM 1: Test the preliminary efficacy of the DM-CCT intervention on glycemic control and quality of life for inner-city AAs with T2DM.AIM 2: Test the preliminary efficacy of the DM-CCT intervention on self-care behaviors and psychological health for inner-city AAs with T2DM.AIM 3: Estimate the cost of delivery of the DM-CCT and UCT interventions in preparation for future cost effectiveness analysis.

How does the DM-CCT, DM-UCT treatment for type 2 diabetes differ from other treatments?

The DM-CCT, DM-UCT treatment for type 2 diabetes is unique because it involves using cash incentives to encourage better self-management of the condition, which is different from traditional treatments that focus solely on medication or lifestyle changes.1234

Who Is on the Research Team?

JA

Jennifer A Campbell, PhD

Principal Investigator

State University at Buffalo

Are You a Good Fit for This Trial?

This trial is for African Americans living in inner city areas, aged 18 or older, with poorly controlled Type 2 Diabetes (HbA1c ≥8%), and earning around the federal poverty level. They must speak English and not be involved in other diabetes trials, have a life expectancy of at least six months, and no drug abuse issues or severe mental health conditions.

Inclusion Criteria

Income greater or equal to 133% of federal poverty level or Medicaid eligible
I have type 2 diabetes with an HbA1c level of 8% or higher.
Self-report as African American
See 2 more

Exclusion Criteria

Participation in other diabetes clinical trials
Alcohol or drug abuse/dependency
Life expectancy <6 months
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive cash transfers conditional on attending biweekly virtual diabetes education/skills training and stress/coping sessions for 6 months

6 months
12 virtual sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • DM-CCT
  • DM-UCT
Trial Overview The study compares two approaches: DM-CCT involves biweekly virtual education on diabetes management plus stress coping skills tied to cash rewards; DM-UCT provides unconditional cash without these requirements. The goal is to see which method better improves blood sugar control, self-care behaviors, quality of life, and psychological health.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Diabetes-Tailored CCTs (DM-CCT) InterventionExperimental Treatment1 Intervention
Participants randomized to DM-CCT will receive cash transfers of $500 per month for 6 months, but the cash transfers will be conditional on attending a 60-minute diabetes education/skills training (30 minutes) and stress/coping (30 minutes) session delivered by trained nurses every 2 weeks for 6 months (12 sessions). Therefore, they will only receive cash transfer payments if they attend two sessions per month.
Group II: Unconditional Cash Transfer-UCTs InterventionActive Control1 Intervention
Participants randomized to UCT will receive cash transfers of $500 per month for 6 months, but there will be no conditions attached. Therefore, they will receive cash transfer payments every month. However, to control for content and attention, participants will receive mailed version of the diabetes education/skills training materials every two weeks on the same schedule as the DM-CCT telephone sessions.

Find a Clinic Near You

Who Is Running the Clinical Trial?

State University of New York at Buffalo

Lead Sponsor

Trials
279
Recruited
52,600+

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Published Research Related to This Trial

A qualitative study involving 12 patients with diabetes revealed that 83% were interested in using financial incentives to enhance their self-management of the condition.
Incentives can help patients during the initial learning phase of developing healthy habits and also acknowledge their efforts during stable management phases, but careful planning is needed to prevent a decrease in intrinsic motivation.
An exploration of attitudes toward the use of patient incentives to support diabetes self-management.Blondon, K., Klasnja, P., Coleman, K., et al.[2018]

Citations

The effect of individual and mixed rewards on diabetes management: A feasibility randomized controlled trial. [2020]
An exploration of attitudes toward the use of patient incentives to support diabetes self-management. [2018]
Applying a private sector capitation model to the management of type 2 diabetes in the South African public sector: a cost-effectiveness analysis. [2022]
Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security